Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track MOLN with free AI briefings, catalyst countdowns, and dilution alerts.

MOLN · Molecular Partners AG

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

Follow MOLN by email Get an email when MOLN pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about MOLN, unsubscribe in one click. Privacy

📣 What MOLN Says Is Next

in 2027 · “A data update from the trial is expected in 2027, and completion of the study in 2028.”
Company press release, Jul 20, 2026 · SEC filing
in 2027 · “Initial data from the MP0712 Phase 1/2a study are expected within the next months, with a more comprehensive dataset on safety and efficacy in 2027.”
Company press release, Jul 7, 2026 · SEC filing
in 2027 · “Initial data from the MP0712 Phase 1/2a study are expected in the upcoming months, with a more comprehensive dataset on safety and efficacy in 2027.”
Company press release, Jul 2, 2026 · SEC filing

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

💰 Cash Runway & Dilution Risk

Dilution pressure: 10 · Low

Cash runway not available
Shelf registration (F-3, Apr 2025) +10

Recent financing filings on SEC EDGAR:

Apr 11, 2025 · Shelf registration, up to $300M · F-3
Oct 25, 2024 · Underwritten offering · 424B5

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when MOLN files for a raise →

Get the full MOLN picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for MOLN and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z